Loramyc

SpePharm UK has launched Loramyc (miconazole), a muco-adhesive buccal tablet for the treatment of oropharyngeal candidiasis in immunocompromised patients.

One tablet is applied once daily to the upper gum just above an incisor tooth after brushing teeth for seven to 14 days.

View Loramyc drug record

Futher information: SpePharm

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases